QCG
CL icon

Quadrant Capital Group’s Colgate-Palmolive CL Stock Holding History

Quadrant Capital Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$976K Sell
11,453
-14,971
-57% -$1.33M 0.03% 584
2025
Q4 		$2.09M Buy
26,424
+2,617
+11% +$205K 0.06% 248
2025
Q3 		$1.9M Buy
23,807
+10,132
+74% +$864K 0.06% 267
2025
Q2 		$1.24M Buy
13,675
+486
+4% +$44.4K 0.04% 373
2025
Q1 		$1.24M Buy
13,189
+8,014
+155% +$718K 0.05% 318
2024
Q4 		$470K Sell
5,175
-130
-2% -$12.4K 0.03% 349
2024
Q3 		$551K Buy
5,305
+160
+3% +$16.3K 0.04% 314
2024
Q2 		$499K Buy
5,145
+667
+15% +$61.5K 0.04% 319
2024
Q1 		$403K Sell
4,478
-34
-0.8% -$2.88K 0.03% 364
2023
Q4 		$360K Sell
4,512
-1,010
-18% -$75.9K 0.03% 386
2023
Q3 		$393K Sell
5,522
-596
-10% -$44.6K 0.04% 326
2023
Q2 		$471K Sell
6,118
-1,024
-14% -$79.3K 0.05% 268
2023
Q1 		$537K Buy
7,142
+2,887
+68% +$215K 0.06% 254
2022
Q4 		$335K Buy
4,255
+480
+13% +$36K 0.04% 333
2022
Q3 		$265K Sell
3,775
-682
-15% -$53.5K 0.04% 343
2022
Q2 		$357K Buy
4,457
+2,444
+121% +$191K 0.05% 280
2022
Q1 		$152K Sell
2,013
-769
-28% -$60.9K 0.02% 534
2021
Q4 		$237K Sell
2,782
-195
-7% -$15.2K 0.03% 394
2021
Q3 		$225K Buy
2,977
+30
+1% +$2.38K 0.03% 354
2021
Q2 		$240K Buy
2,947
+130
+5% +$10.6K 0.03% 334
2021
Q1 		$222K Buy
2,817
+144
+5% +$11.3K 0.04% 323
2020
Q4 		$229K Buy
2,673
+232
+10% +$19.2K 0.04% 273
2020
Q3 		$188K Buy
2,441
+503
+26% +$38.4K 0.04% 270
2020
Q2 		$142K Sell
1,938
-2,078
-52% -$148K 0.03% 349
2020
Q1 		$270K Buy
4,016
+1,588
+65% +$112K 0.05% 317
2019
Q4 		$153K Sell
2,428
-207
-8% -$14.1K 0.02% 769
2019
Q3 		$183K Sell
2,635
-803
-23% -$58.3K 0.03% 627
2019
Q2 		$238K Buy
3,438
+876
+34% +$62.2K 0.04% 486
2019
Q1 		$166K Buy
2,562
+932
+57% +$60.2K 0.03% 565
2018
Q4 		$91K Sell
1,630
-6
-0.4% -$375 0.02% 642
2018
Q3 		$100K Buy
1,636
+281
+21% +$18.7K 0.03% 408
2018
Q2 		$79K Sell
1,355
-247
-15% -$16.2K 0.03% 486
2018
Q1 		$108K Buy
1,602
+941
+142% +$67.7K 0.04% 384
2017
Q4 		$42K Sell
661
-80
-11% -$5.84K 0.02% 668
2017
Q3 		$47K Sell
741
-51
-6% -$3.68K 0.02% 621
2017
Q2 		$35K Buy
792
+119
+18% +$8.84K 0.02% 668
2017
Q1 		$43K Buy
673
+158
+31% +$11.1K 0.02% 610
2016
Q4 		$28K Sell
515
-970
-65% -$66.5K 0.01% 632
2016
Q3 		$103K Buy
1,485
+991
+201% +$73.3K 0.07% 241
2016
Q2 		$31K Sell
494
-742
-60% -$52.8K 0.02% 551
2016
Q1 		$81K Buy
1,236
+129
+12% +$8.58K 0.05% 269
2015
Q4 		$69K Buy
1,107
+128
+13% +$8.52K 0.05% 310
2015
Q3 		$59K Buy
979
+808
+473% +$52.8K 0.04% 364
2015
Q2 		$9K Buy
+171
New +$11.6K 0.01% 724

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Quadrant Capital Group's CL Position: Q1 2026 in Review

Quadrant Capital Group reduced its Colgate-Palmolive (CL) stake by 57% in Q1 2026, selling an estimated $1.33M and leaving 11,453 shares worth $976K. The position accounts for 0.03% of the portfolio, ranked #584.

Quadrant Capital Group first reported a position in CL in Q2 2015 and has held it in 44 quarters since. The position peaked at $2.09M in Q4 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Quadrant Capital Group held 11,453 shares of Colgate-Palmolive worth $976K as of Q1 2026.
  • Quadrant Capital Group sold 14,971 Colgate-Palmolive shares in Q1 2026, an estimated $1.33M.
  • Colgate-Palmolive made up 0.03% of Quadrant Capital Group's portfolio in Q1 2026, its #584 holding.
  • Quadrant Capital Group first reported a position in Colgate-Palmolive in Q2 2015 and has held it in 44 quarters since.
  • Quadrant Capital Group's Colgate-Palmolive position peaked at $2.09M in Q4 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.